ECDC public health response to the threat of resistant gonorrhoea in Europe.
M
M
Van de Laar
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003140:Communicable Disease Control / Q000458:organization & administration*; D024881:Drug Resistance, Bacterial; D005060:Europe; D005260:Female; D006069:Gonorrhea / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D015994:Incidence; D007318:Inservice Training; D008297:Male; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects* / Q000302:isolation & purification; D009937:Organizational Objectives; D011159:Population Surveillance; D017410:Practice Guidelines as Topic; D015980:Public Health Practice / Q000592:standards*; D018570:Risk Assessment / Q000379:methods / Q000592:standards
D000900:Anti-Bacterial Agents